See more : Cirrus Aircraft Ltd (2507.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tiansheng Pharmaceutical Group Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Komplett ASA (KOMPL.OL) Income Statement Analysis – Financial Results
- Grupo Media Capital, SGPS, S.A. (MCP.LS) Income Statement Analysis – Financial Results
- Zbom Home Collection Co.,Ltd (603801.SS) Income Statement Analysis – Financial Results
- Scirocco Energy Plc (SCIR.L) Income Statement Analysis – Financial Results
- AAK AB (publ.) (AAK.ST) Income Statement Analysis – Financial Results
Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
About Tiansheng Pharmaceutical Group Co., Ltd.
Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, tumor, hepatobiliary, blood, surgery, diabetes, and others. The company was founded in 2001 and is based in Chongqing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 579.33M | 606.99M | 736.69M | 1.20B | 1.68B | 2.17B | 2.26B | 2.09B | 1.84B | 1.66B | 1.42B | 1.00B |
| Cost of Revenue | 322.36M | 263.59M | 432.70M | 852.83M | 1.21B | 1.55B | 1.58B | 1.47B | 1.31B | 1.20B | 997.77M | 715.48M |
| Gross Profit | 256.97M | 343.40M | 303.98M | 349.91M | 472.01M | 622.86M | 682.89M | 612.25M | 534.45M | 460.99M | 424.19M | 288.64M |
| Gross Profit Ratio | 44.36% | 56.57% | 41.26% | 29.09% | 28.13% | 28.68% | 30.20% | 29.34% | 29.00% | 27.71% | 29.83% | 28.75% |
| Research & Development | 30.92M | 34.27M | 29.24M | 22.46M | 36.29M | 39.78M | 33.86M | 35.12M | 21.18M | 19.13M | 25.15M | 14.68M |
| General & Administrative | 32.97M | 35.96M | 32.35M | 51.34M | 44.49M | 29.21M | 30.14M | 22.86M | 21.24M | 23.16M | 106.30M | 68.71M |
| Selling & Marketing | 180.28M | 267.08M | 228.43M | 300.48M | 410.14M | 370.25M | 191.21M | 179.74M | 151.67M | 136.34M | 122.23M | 90.61M |
| SG&A | 316.46M | 303.05M | 260.78M | 351.82M | 454.63M | 399.46M | 221.34M | 202.60M | 172.91M | 159.50M | 228.53M | 159.32M |
| Other Expenses | 3.17M | 70.49M | 47.34M | 71.37M | 82.91M | 66.48M | 57.52M | 39.21M | 41.01M | 27.49M | 20.50M | 23.22M |
| Operating Expenses | 350.55M | 407.81M | 337.37M | 445.65M | 573.84M | 505.72M | 312.72M | 321.15M | 269.34M | 242.90M | 234.33M | 165.18M |
| Cost & Expenses | 672.91M | 671.40M | 770.07M | 1.30B | 1.78B | 2.05B | 1.89B | 1.80B | 1.58B | 1.45B | 1.23B | 880.66M |
| Interest Income | 8.40M | 7.52M | 16.84M | 5.92M | 1.46M | 2.02M | 2.16M | 1.30M | 1.28M | 4.19M | 0.00 | 17.14M |
| Interest Expense | 14.99M | 15.78M | 24.36M | 38.89M | 37.65M | 42.18M | 28.77M | 35.52M | 35.08M | 37.36M | 26.60M | 0.00 |
| Depreciation & Amortization | 107.26M | 110.48M | 93.24M | 121.95M | 116.72M | 115.07M | 106.88M | 83.68M | 65.66M | 59.82M | 49.33M | 34.74M |
| EBITDA | 27.53M | 39.32M | 59.90M | -370.23M | -82.28M | 187.73M | 427.97M | 397.84M | 302.96M | 264.93M | 239.19M | 158.21M |
| EBITDA Ratio | 4.75% | 9.31% | 11.33% | -0.69% | 0.20% | 9.45% | 20.57% | 19.37% | 20.24% | 18.54% | 17.80% | 15.58% |
| Operating Income | -93.57M | -51.20M | -6.52M | -95.74M | -102.66M | 96.63M | 309.65M | 238.66M | 206.92M | 173.34M | 149.63M | 107.67M |
| Operating Income Ratio | -16.15% | -8.43% | -0.88% | -7.96% | -6.12% | 4.45% | 13.69% | 11.44% | 11.23% | 10.42% | 10.52% | 10.72% |
| Total Other Income/Expenses | -1.15M | 589.94K | 6.55M | -34.24M | -9.11M | -59.58M | -4.41M | 39.20M | 39.68M | 27.01M | 19.27M | 7.38M |
| Income Before Tax | -94.72M | -84.12M | -54.44M | -534.58M | -229.64M | 37.05M | 305.25M | 276.93M | 246.60M | 200.35M | 168.91M | 130.84M |
| Income Before Tax Ratio | -16.35% | -13.86% | -7.39% | -44.45% | -13.68% | 1.71% | 13.50% | 13.27% | 13.38% | 12.04% | 11.88% | 13.03% |
| Income Tax Expense | -1.01M | 7.44M | 17.89M | -40.99M | -10.70M | 21.42M | 49.44M | 42.88M | 45.30M | 26.48M | 35.88M | 17.64M |
| Net Income | -93.07M | -91.55M | -72.34M | -493.59M | -218.94M | 15.62M | 248.58M | 224.50M | 191.98M | 164.57M | 125.95M | 109.99M |
| Net Income Ratio | -16.07% | -15.08% | -9.82% | -41.04% | -13.05% | 0.72% | 10.99% | 10.76% | 10.42% | 9.89% | 8.86% | 10.95% |
| EPS | -0.29 | -0.29 | -0.23 | -1.55 | -0.69 | 0.06 | 0.84 | 0.94 | 0.81 | 0.75 | 0.59 | 0.55 |
| EPS Diluted | -0.29 | -0.29 | -0.23 | -1.55 | -0.69 | 0.06 | 0.84 | 0.94 | 0.81 | 0.75 | 0.59 | 0.55 |
| Weighted Avg Shares Out | 318.00M | 318.00M | 318.00M | 318.00M | 318.00M | 247.50M | 294.44M | 238.83M | 237.98M | 218.46M | 212.27M | 201.18M |
| Weighted Avg Shares Out (Dil) | 318.00M | 318.00M | 318.00M | 318.00M | 318.00M | 247.50M | 294.44M | 238.83M | 237.99M | 218.46M | 212.27M | 201.20M |
Source: https://incomestatements.info
Category: Stock Reports